| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 147, Issue 2 561-568, Copyright © 1991 by American Association of Immunologists
ARTICLES |
PJ Morrissey, P Conlon, K Charrier, S Braddy, A Alpert, D Williams, AE Namen and D Mochizuki
Immunex Corporation, Seattle, WA 98101.
Normal mice were injected with IL-7 (500 ng, twice daily) for various periods of time up to 6 days and the cellularity and phenotypic composition of the thymus, spleen, lymph node, and bone marrow was assessed. After 6 days of treatment, significant increases in the cellularity of the spleen, lymph node, and bone marrow were observed which returned to the normal range within 6 days after cessation of treatment. After 3 days of IL-7 treatment, increased numbers of B220+/surface(s) IgM- bone marrow cells were observed. After 6 days of treatment, these numbers were still further increased and a significant population of B220+/sIgM- cells were observed in the spleen. The numbers of c mu+/sIgM- cells were also increased in the IL-7-treated mice. Analysis of the expression of B220 and BP-1 on the sIgM- bone marrow cells revealed that the B220+/BP-1+ population was dramatically increased after IL-7 treatment and the size of the B220+/BP-1- population did not differ from control mice. The pre-B cell numbers declined rapidly after the cessation of IL-7 treatment. After 6 days of IL-7 treatment, a twofold increase in the number of B cells in the spleen and lymph node was observed. The B cell numbers declined to normal values within 6 days after the cessation of IL-7 administration. In the spleens of the IL-7-treated mice, there was a significant increase in the number of B cells with an immature phenotype (e.g., sIgMhi/sIgDlo, decreased levels of Ia and FcR expression). The numbers of CD8+ and CD4+ T cells were also increased in the lymph node and spleen of the IL-7-treated mice. These numbers declined to normal levels after the cessation of IL-7 treatment.
This article has been cited by other articles:
|
|
 |
|
  O. Boyman, C. Ramsey, D. M. Kim, J. Sprent, and C. D. Surh IL-7/Anti-IL-7 mAb Complexes Restore T Cell Development and Induce Homeostatic T Cell Expansion without Lymphopenia J. Immunol., June 1, 2008; 180(11): 7265 - 7275. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. A. Duthie, L. C. Osborne, L. J. Foster, and N. Abraham Proteomics Analysis of Interleukin (IL)-7-induced Signaling Effectors Shows Selective Changes in IL-7R{alpha}449F Knock-in T Cell Progenitors Mol. Cell. Proteomics, October 1, 2007; 6(10): 1700 - 1710. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Lai, R. A. Zeff, and I. Goldschneider A recombinant single-chain IL-7/HGFbeta hybrid cytokine induces juxtacrine interactions of the IL-7 and HGF (c-Met) receptors and stimulates the proliferation of CFU-S12, CLPs, and pre-pro-B cells Blood, March 1, 2006; 107(5): 1776 - 1784. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Bosco, F. Agenes, and R. Ceredig Effects of Increasing IL-7 Availability on Lymphocytes during and after Lymphopenia-Induced Proliferation J. Immunol., July 1, 2005; 175(1): 162 - 170. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Pellegrini, P. Bouillet, M. Robati, G. T. Belz, G. M. Davey, and A. Strasser Loss of Bim Increases T Cell Production and Function in Interleukin 7 Receptor-deficient Mice J. Exp. Med., November 1, 2004; 200(9): 1189 - 1195. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Tretter, A. E. Ross, D. I. Dordai, and S. Desiderio Mimicry of Pre-B Cell Receptor Signaling by Activation of the Tyrosine Kinase Blk J. Exp. Med., December 15, 2003; 198(12): 1863 - 1873. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-K. Lee, J. F. Kalinowski, S. L. Jastrzebski, L. Puddington, and J. A. Lorenzo Interleukin-7 Is a Direct Inhibitor of in Vitro Osteoclastogenesis Endocrinology, August 1, 2003; 144(8): 3524 - 3531. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. Napolitano, C. A. Stoddart, M. B. Hanley, E. Wieder, and J. M. McCune Effects of IL-7 on Early Human Thymocyte Progenitor Cells In Vitro and in SCID-hu Thy/Liv Mice J. Immunol., July 15, 2003; 171(2): 645 - 654. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. C. Kieper, J. T. Tan, B. Bondi-Boyd, L. Gapin, J. Sprent, R. Ceredig, and C. D. Surh Overexpression of Interleukin (IL)-7 Leads to IL-15-independent Generation of Memory Phenotype CD8+ T Cells J. Exp. Med., June 17, 2002; 195(12): 1533 - 1539. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Lai and I. Goldschneider Cutting Edge: Identification of a Hybrid Cytokine Consisting of IL-7 and the {beta}-Chain of the Hepatocyte Growth Factor/Scatter Factor J. Immunol., October 1, 2001; 167(7): 3550 - 3554. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Alpdogan, C. Schmaltz, S. J. Muriglan, B. J. Kappel, M.-A. Perales, J. A. Rotolo, J. A. Halm, B. E. Rich, and M. R. M. van den Brink Administration of interleukin-7 after allogeneic bone marrow transplantation improves immune reconstitution without aggravating graft-versus-host disease Blood, October 1, 2001; 98(7): 2256 - 2265. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. Geiselhart, C. A. Humphries, T. A. Gregorio, S. Mou, J. Subleski, and K. L. Komschlies IL-7 Administration Alters the CD4:CD8 Ratio, Increases T Cell Numbers, and Increases T Cell Function in the Absence of Activation J. Immunol., March 1, 2001; 166(5): 3019 - 3027. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Andrew and R. Aspinall IL-7 and Not Stem Cell Factor Reverses Both the Increase in Apoptosis and the Decline in Thymopoiesis Seen in Aged Mice J. Immunol., February 1, 2001; 166(3): 1524 - 1530. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E. Sims, D. E. Williams, P. J. Morrissey, K. Garka, D. Foxworthe, V. Price, S. L. Friend, A. Farr, M. A. Bedell, N. A. Jenkins, et al. Molecular Cloning and Biological Characterization of a Novel Murine Lymphoid Growth Factor J. Exp. Med., August 28, 2000; 192(5): 671 - 680. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Hameg, C. Gouarin, J.-M. Gombert, S. Hong, L. Van Kaer, J.-F. Bach, and A. Herbelin IL-7 Up-Regulates IL-4 Production by Splenic NK1.1+ and NK1.1- MHC Class I-Like/CD1-Dependent CD4+ T Cells J. Immunol., June 15, 1999; 162(12): 7067 - 7074. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Lu, P. Chaudhury, and D. G. Osmond Regulation of Cell Survival During B Lymphopoiesis: Apoptosis and Bcl-2/Bax Content of Precursor B Cells in Bone Marrow of Mice with Altered Expression of IL-7 and Recombinase-Activating Gene-2 J. Immunol., February 15, 1999; 162(4): 1931 - 1940. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Marshall, H. E. Fleming, G. E. Wu, and C. J. Paige Modulation of the IL-7 Dose-Response Threshold During Pro-B Cell Differentiation Is Dependent on Pre-B Cell Receptor Expression J. Immunol., December 1, 1998; 161(11): 6038 - 6045. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. D. McKenna, F. Chen, L. Lai, and I. Goldschneider Identification of an IL-7-Associated Pre-Pro-B Cell Growth-Stimulating Factor (PPBSF). I. Production of the Non-IL-7 Component by Bone Marrow Stromal Cells from IL-7 Gene-Deleted Mice J. Immunol., March 1, 1998; 160(5): 2272 - 2279. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Miyaura, Y. Onoe, M. Inada, K. Maki, K. Ikuta, M. Ito, and T. Suda Increased B-lymphopoiesis by interleukin 7 induces bone loss in mice with intact ovarian function: Similarity to estrogen deficiency PNAS, August 19, 1997; 94(17): 9360 - 9365. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
